Literature DB >> 2191050

The role of adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin disease--1990 update.

B J Nickoloff1, C E Griffiths, J N Barker.   

Abstract

In 1986 it was discovered that cultured human keratinocytes, when treated with gamma interferon, attract and bind T lymphocytes and monocytes. More is now known about trafficking of inflammatory cells in the skin, with specific molecular details involving various cytokines, chemotactic factors, and adhesion molecules. One key element is the in vivo movement of T cells that express LFA-1 into the epidermis, and their subsequent binding to keratinocytes via the surface expression of intercellular adhesion molecule-1 (ICAM-1). This interaction represents a common immunologic pathway, which has been identified in a wide variety of different skin diseases. This review provides a synopsis of advances in this field, which have grown rapidly during the past few years, and adds recent results dealing with coordinate regulation at the gene-transcriptional level of keratinocyte chemotactic factor production and adhesion molecule expression. Moreover, epidermal keratinocytes appear to play a pre-eminent role in the skin, serving as transducing elements converting exogenously applied low-molecular-weight chemical stimuli such as phorbol ester and urushiol (the active ingredient in poison ivy extracts) into the production of endogenously derived immunoregulatory proteins. These keratinocyte-derived molecules may then influence immunocytes and endothelial cells to further amplify the inflammatory response. The identification of keratinocyte-derived molecules such as IL-8 and ICAM-1, which influence the chemotaxis and adherence of T cells, adds substantial evidence supporting an active participatory role for keratinocytes in cutaneous immunohomeostasis. Finally, we highlight the importance of these immunoregulatory molecules in two malignant cutaneous disorders (cutaneous T-cell lymphoma and basal-cell carcinoma) and attempt to integrate these new findings into novel pathophysiologic models for two inflammatory dermatoses (rhus dermatitis and psoriasis).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2191050     DOI: 10.1111/1523-1747.ep12876134

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  21 in total

Review 1.  Induction and control of lichenoid tissue reactions.

Authors:  T Shiohara; N Moriya; M Nagashima
Journal:  Springer Semin Immunopathol       Date:  1992

2.  On the role of AP2 in epithelial-specific gene expression.

Authors:  T Magnaldo; R G Vidal; M Ohtsuki; I M Freedberg; M Blumenberg
Journal:  Gene Expr       Date:  1993

Review 3.  The spectrum of cutaneous patch-test reactions in patients with atopic dermatitis.

Authors:  J M Hanifin; P A Klas
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

Review 4.  The skin as an immune organ.

Authors:  J K Salmon; C A Armstrong; J C Ansel
Journal:  West J Med       Date:  1994-02

5.  4A11, a monoclonal antibody recognizing a novel antigen expressed on aberrant vascular endothelium. Upregulation in an in vivo model of contact dermatitis.

Authors:  A E Koch; B J Nickoloff; J Holgersson; B Seed; G K Haines; J C Burrows; S J Leibovich
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

6.  Epidermotropic neutrophilic granulocytes express MAC-1 (CD11b/CD18) rather than LFA-1 (CD11a/CD18).

Authors:  P von den Driesch
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

7.  Expression and polarization of intercellular adhesion molecule-1 on human intestinal epithelia: consequences for CD11b/CD18-mediated interactions with neutrophils.

Authors:  C A Parkos; S P Colgan; M S Diamond; A Nusrat; T W Liang; T A Springer; J L Madara
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

8.  Expression of different immunological markers by cultured human melanocytes.

Authors:  N Smit; I Le Poole; R van den Wijngaard; A Tigges; W Westerhof; P Das
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

9.  Expression of intercellular adhesion molecule-1 (ICAM-1) and OKM5 in UVA- and UVB-induced lesions in patients with lupus erythematosus and polymorphous light eruption.

Authors:  E Stephansson; A M Ros
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

10.  A truncated recombinant intercellular adhesion molecule-1 inhibits adhesion of leukemic cell lines to upregulated endothelial cells.

Authors:  L Ross; C M Davis; L Molony
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-12       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.